Hydrocortisone butyrate
- Generic Name
- Hydrocortisone butyrate
- Brand Names
- Locoid
- Drug Type
- Small Molecule
- Chemical Formula
- C25H36O6
- CAS Number
- 13609-67-1
- Unique Ingredient Identifier
- 05RMF7YPWN
Overview
No overview information available.
Background
No background information available.
Indication
For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.
Associated Conditions
- Atopic Dermatitis
- Corticosteroid responsive, Inflammatory Dermatosis
- Corticosteroid responsive, pruritic Dermatosis
- Pruritic, corticosteroid responsive, Inflammatory Dermatosis
Clinical Trials
FDA Approved Products
Locoid
Manufacturer:Bausch Health US, LLC
Route:TOPICAL
Strength:1 mg in 1 mL
Approved: 2023/10/30
NDC:16781-392
Aquax-H
Manufacturer:Pella Pharmaceuticals Co. ltd
Route:TOPICAL
Strength:30 mg in 30 g
Approved: 2023/12/26
NDC:82160-127
Hydrocortisone Butyrate
Manufacturer:Taro Pharmaceuticals U.S.A., Inc.
Route:TOPICAL
Strength:1 mg in 1 g
Approved: 2021/04/06
NDC:51672-4074
Hydrocortisone Butyrate
Manufacturer:Lupin Pharmaceuticals, Inc.
Route:TOPICAL
Strength:1 mg in 1 mL
Approved: 2019/12/13
NDC:68180-951
Hydrocortisone Butyrate
Manufacturer:Taro Pharmaceuticals U.S.A., Inc.
Route:TOPICAL
Strength:1 mg in 1 mL
Approved: 2021/04/06
NDC:51672-4061
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath